Delivery Order SPE2DR25D6035-SPE2DR26FBLDH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Janumet 50-1,000 mg tablets (180 count) with a contract ceiling value of $4,393.68. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion on July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a contract value of $4,939.13. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The ultimate completion date is September 16, 2025, and the work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Janumet 50-1,000 mg tablets in quantities of 1,000 units, with a ceiling value of $2,012.06. This is a firm fixed price delivery order with an ultimate completion date of August 12, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a ceiling value of $10,920.04. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 11, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Janumet 50-1,000 mg tablets in a quantity of 180 units, with a ceiling value of $4,327.00. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,246.37 to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count bottles) on December 3, 2025, with an ultimate completion date of December 4, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a direct delivery order under AmerisourceBergen's existing pharmaceutical supply vehicle. The pharmaceutical product will be performed and delivered from the company's facility in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) under a firm fixed-price contract valued at $13,839.99. The delivery order is non-set-aside and competitively awarded, with an ultimate completion date of August 21, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Janumet 50-1,000 mg tablets (180-count units) on August 27, 2025, with a ceiling value of $1,535.39 and an ultimate completion date of August 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through competitive procedures. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Janumet 50-1,000 mg tablets in a quantity of 180 units, with a ceiling value of $1,730.18. This firm fixed-price delivery order, without set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Janumet 50-1,000 mg tablets (60-count units) with a contract ceiling value of $4,606.94. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded procurement under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's corporate office...
- SPE2DR25D6035Indefinite Delivery Contract
- SPE2DR25D6035-SPE2DR26FBLDHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 13, 2025, for the supply of Janumet 50-1,000 mg tablets (180-count units) with a contract ceiling value of $2,374.30. This is a firm fixed price delivery order with no set-aside designation, issued competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. The order is scheduled for completion by December 15, 2025, and will be fulfilled from AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's existing SPE2DX Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support platform enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide. The delivery order fulfills critical pharmaceutical needs for federal medical procurement, supporting the Defense Health Agency and other government healthcare systems with essential diabetes management medications as part of the company's extensive portfolio of brand-name and generic drugs, vaccines, and specialized medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 12/12/25 |